Report: Solana's DeFi Ecosystem Shifts from Public, Passive Liquidity Pools to Private Execution DEX
On May 14, Pine Analytics released a report indicating that Solana's DeFi ecosystem has shifted from public, passive liquidity pools to private execution DEXs. New DEXs like SolFi, Obric v2, and ZeroFi, although not operating front-end interfaces, have processed 40-65% of on-chain trading volume through the aggregator Jupiter. These DEXs adopt four core designs:
1. Execute trades only through the Jupiter aggregator;
2. Pricing based on real-time oracles;
3. Use private vaults instead of public liquidity pools;
4. Selective quoting based on inventory. This model effectively avoids MEV attacks and toxic order flow, showing significant advantages in major trading pairs like SOL and stablecoins. Solana's current architecture (single leader, MEV auctions) puts public quoting at a disadvantage, but upcoming upgrades like concurrent leaders may change this situation. While the private market-making model enhances execution efficiency, it also reduces the openness and composability of DeFi. This evolution reflects that Solana's ecosystem is gradually forming a unique liquidity supply method that matches its technical architecture.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
